Naghshband Z, Kumar L, Mandappa S, Murthy ASN, Malini SS. Visceral adiposity index and lipid accumulation product as diagnostic markers of metabolic syndrome in South Indians with polycystic ovary syndrome. J Hum Reprod Sci. 2021;14(3):234. https://doi.org/10.4103/jhrs.jhrs_12_21.
CAS Article PubMed PubMed Central Google Scholar
Hsieh Y-C, Yang P-K, Chen M-J. Metabolic Syndrome in Polycystic Ovary Syndrome. J Reprod Infertil.2021:1–11.https://doi.org/10.1142/S2661318221500158.
Kumarendran B, Sumilo D, O’Reilly MW, Toulis KA, Gokhale KM, Wijeyaratne CN, et al. Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol. 2019;180(4):265–72. https://doi.org/10.1530/EJE-18-0693.
CAS Article PubMed PubMed Central Google Scholar
Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study. Fertil Steril. 2015;103(2):537–41. https://doi.org/10.1016/j.fertnstert.2014.10.033.
CAS Article PubMed Google Scholar
Villarroel C, Merino P, Lopez P, Eyzaguirre F, Van Velzen A, Iniguez G, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Müllerian hormone. Hum Reprod. 2011;26(10):2861–8https://doi.org/10.1093/humrep/der223.
CAS Article PubMed Google Scholar
Tata B, Mimouni NEH, Barbotin A-L, Malone SA, Loyens A, Pigny P, et al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834–46. https://doi.org/10.1038/s41591-018-0035-5.
CAS Article PubMed PubMed Central Google Scholar
Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015;13(1):1–10. https://doi.org/10.1186/s12958-015-0134-9.
Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, et al. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women. Taiwan J Obstet Gynecol. 2018;57(4):499–506. https://doi.org/10.1016/j.tjog.2018.06.004.
Ahmed N, Batarfi AA, Bajouh OS, Bakhashab S. Serum anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms. Diagnostics. 2019;9(4):136. https://doi.org/10.3390/diagnostics9040136.
CAS Article PubMed Central Google Scholar
Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndromeJ. Clin Endocrinol Metab. 2006;91(3):941–5. https://doi.org/10.1210/jc.2005-2076.
Wiweko B, Maidarti M, Priangga MD, Shafira N, Fernando D, Sumapraja K, et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J Assist Reprod Genet. 2014;31(10):1311–6. https://doi.org/10.1007/s10815-014-0300-6.
Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123–9. https://doi.org/10.1093/humrep/der297.
CAS Article PubMed Google Scholar
Song DK, Oh JY, Lee H, Sung YA. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value. Korean J Intern Med. 2016;32(4):690–8. https://doi.org/10.3904/kjim.2016.038.
Tremellen K, Zander-Fox D. Serum anti‐Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Aust N Z J Obstet Gynaecol. 2015;55(4):384–9. https://doi.org/10.1111/ajo.12366.
Saxena U, Ramani M, Singh P. Role of AMH as diagnostic tool for polycystic ovarian syndrome. J Obstet Gynaecol India. 2018;68(2):117–22. https://doi.org/10.1007/s13224-017-1066-4.
CAS Article PubMed Google Scholar
Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, et al. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod. 2013;28(4):1077–83https://doi.org/10.1093/humrep/det015.
CAS Article PubMed Google Scholar
Chao K-C, Ho C-H, Shyong W-Y, Huang C-Y, Tsai S-C, Cheng H-Y, et al. Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women. J Chin Med Assoc. 2012;75(2):70–4. https://doi.org/10.1016/j.jcma.2011.12.007.
CAS Article PubMed Google Scholar
Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod.2012 Aug;27(8):2494–502. https://doi.org/10.1093/humrep/des213. Epub 2012 Jun 12.
Lin Y-H, Chiu W-C, Wu C-H, Tzeng C-R, Hsu C-S, Hsu M-I. Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230–5. https://doi.org/10.1016/j.fertnstert.2011.04.003.
Li HWR, Anderson RA, Yeung WSB, Ho PC, Ng EHY. Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrheaFertil. Steril. 2011;96(3):774–9. https://doi.org/10.1016/j.fertnstert.2011.06.016.
Li L, Chen X, Mo Y, Chen Y, Wenig M, Yang D. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr. 2010;122(17):519–24. https://doi.org/10.1007/s00508-010-1426-x.
CAS Article PubMed Google Scholar
Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010;94(3):1118–21. https://doi.org/10.1016/j.fertnstert.2009.11.002.
CAS Article PubMed Google Scholar
Woo H-Y, Kim K-H, Rhee E-J, Park H, Lee M-K. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J.2012;59(9):781–90. https://doi.org/10.1507/endocrj.ej12-0055.
Sahmay S, Aydin Y, Oncul M, Senturk LM. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet. 2014;31(2):213–20. https://doi.org/10.1007/s10815-013-0149-0.
Tehrani FR, Rahmati M, Mahboobifard F, Firouzi F, Hashemi N, Azizi F. Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):1–10. https://doi.org/10.1186/s12958-021-00755-8.
Do Kyeong Song J-YO, Lee H, Sung Y-A. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value. Korean J Intern Med. 2017;32(4):690. https://doi.org/10.3904/kjim.2016.038.
CAS Article PubMed Google Scholar
Yue C-Y, Lu L-k-y, Li M, Zhang Q-L, Ying C-M. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS ONE. 2018;13(8):e0203129. https://doi.org/10.1371/journal.pone.0203129.
CAS Article PubMed PubMed Central Google Scholar
de Loos AD, Hund M, Buck K, Meun C, Sillman J, Laven JS. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil Steril. 2021;116(4):1149–57.https://doi.org/10.1016/j.fertnstert.2021.05.094.
Liou T-H, Yang J-H, Hsieh C-H, Lee C-Y, Hsu C-S, Hsu M-I. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960-5.https://doi.org/0.1016/j.fertnstert.2008.09.003.
Aydoğmuş H, Kelekçi S, Elmalı F, Aydoğmuş S. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles. Saudi Med J. 2018;39(10):1011. https://doi.org/10.15537/smj.2018.10.2341.
留言 (0)